Markus Müller, President at Medical University of Vienna, shared a post on LinkedIn:
“Major milestone for Cell Therapy in Austria:
A patient with severe rheumatological autoimmune disease has been treated with CAR-T cells produced in-house at MedUni Vienna/AKH for the first time in Austria.
A collaborative effort of the Department of Transfusion Medicine and Cell Therapy and the Departments of Internal Medicine I & III.”
Read the full article.
Read more about CAR-T cell therapy on OncoDaily.